Found: 35
Select item for more details and to access through your institution.
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Head‐to‐Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 3, p. 476, doi. 10.1002/ana.27008
- By:
- Publication type:
- Article
Pharmacokinetics of 38 Percent Silver Diamine Fluoride in Children.
- Published in:
- Pediatric Dentistry, 2022, v. 44, n. 2, p. 114
- By:
- Publication type:
- Article
[<sup>18</sup>F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer's disease and other neurodegenerative diseases: Biomarkers: Leveraging postmortem collections to validate neuroimaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046262
- By:
- Publication type:
- Article
Glucose metabolism mainly reflects local atrophy and tau pathology at symptomatic stages of Alzheimer's disease: Neuroimaging / Multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043968
- By:
- Publication type:
- Article
Amyloid and tau PET in sporadic early‐onset Alzheimer's disease: Preliminary results from LEADS: LEADS: Sporadic early‐onset Alzheimer's disease in the spotlight.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041613
- By:
- Publication type:
- Article
Comparison of <sup>18</sup>F‐Flortaucipir visual assessment, SUVR quantification and CSF pTau for defining T‐status in the AT(N) framework: Neuroimaging / Multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037276
- By:
- Publication type:
- Article
P2‐439: [<sup>18</sup>F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON‐ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P782, doi. 10.1016/j.jalz.2019.06.2846
- By:
- Publication type:
- Article
[<sup>18</sup>F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1980, doi. 10.2967/jnumed.123.265856
- By:
- Publication type:
- Article
Tau PET Visual Reads: Research and Clinical Applications and Future Directions.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 822, doi. 10.2967/jnumed.122.265017
- By:
- Publication type:
- Article
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01302-w
- By:
- Publication type:
- Article
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 8, p. 845, doi. 10.1001/jamaneurol.2024.1612
- By:
- Publication type:
- Article
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2259, doi. 10.1007/s00259-020-05152-8
- By:
- Publication type:
- Article
Quantitative Amyloid‐PET in Real‐World Practice: Lessons from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082874
- By:
- Publication type:
- Article
Preliminary results investigating synaptic density across the Alzheimer's Disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082447
- By:
- Publication type:
- Article
Amyloid‐PET, tau‐PET, and their association in sporadic early‐onset Alzheimer's Disease: Cross‐sectional and longitudinal data from the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078003
- By:
- Publication type:
- Article
Frequency of repetitive head impacts and influence on clinical variability among male patients with Alzheimer's disease and frontotemporal dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078031
- By:
- Publication type:
- Article
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer's disease in the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079008
- By:
- Publication type:
- Article
Regional patterns of pathological tau accumulation in sporadic early‐onset Alzheimer's disease: Longitudinal tau‐PET in the LEADS Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080217
- By:
- Publication type:
- Article
The Role of Alzheimer's Disease Pathology in Cognition, Brain Volume, and Plasma Biomarker Concentrations in Traumatic Encephalopathy Syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078832
- By:
- Publication type:
- Article
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer's disease in the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081864
- By:
- Publication type:
- Article
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S98, doi. 10.1002/alz.13453
- By:
- Publication type:
- Article
Influence of amyloid and diagnostic syndrome on non‐traditional memory scores in early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S29, doi. 10.1002/alz.13434
- By:
- Publication type:
- Article
Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S8, doi. 10.1002/alz.13160
- By:
- Publication type:
- Article
[<sup>18</sup>F]PI‐2620 PET in four‐repeat tauopathies: a preliminary study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067974
- By:
- Publication type:
- Article
Amyloid Negative, Highly Tau Positive: Clinical Characterization of a Rare Biomarker Profile.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067381
- By:
- Publication type:
- Article
Head‐to‐head comparison between plasma ptau‐217 and Flortaucipir‐PET in amyloid‐positive patients with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064837
- By:
- Publication type:
- Article
Head‐to‐head comparison between plasma ptau‐217 and Flortaucipir‐PET in amyloid‐positive patients with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.067888
- By:
- Publication type:
- Article
Clinical, cognitive and biomarker profiles in dominantly‐inherited versus sporadic early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055016
- By:
- Publication type:
- Article
Head‐to‐head comparison of [<sup>18</sup>F]Flortaucipir and amyloid PET visual reads for differential diagnosis: An international, multi‐center study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056290
- By:
- Publication type:
- Article
White matter hyperintensities and regional tau‐PET signal independently contribute to cognitive deficits in symptomatic patients on the Alzheimer’s disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055667
- By:
- Publication type:
- Article
Imaging measures of molecular pathology and neurodegeneration in dominantly‐inherited and sporadic early‐onset Alzheimer’s Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055023
- By:
- Publication type:
- Article
Cognitive correlations with amyloid, tau and neurodegeneration PET across the Alzheimer's disease age spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055892
- By:
- Publication type:
- Article